XB-ART-53701
World J Gastroenterol
2016 Sep 07;2233:7486-99. doi: 10.3748/wjg.v22.i33.7486.
Show Gene links
Show Anatomy links
Aberrant regulation of Wnt signaling in hepatocellular carcinoma.
Liu LJ
,
Xie SX
,
Chen YT
,
Xue JL
,
Zhang CJ
,
Zhu F
.
???displayArticle.abstract???
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies in the world. Several signaling pathways, including the wingless/int-1 (Wnt) signaling pathway, have been shown to be commonly activated in HCC. The Wnt signaling pathway can be triggered via both catenin β1 (CTNNB1)-dependent (also known as "canonical") and CTNNB1-independent (often referred to as "non-canonical") pathways. Specifically, the canonical Wnt pathway is one of those most frequently reported in HCC. Aberrant regulation from three complexes (the cell-surface receptor complex, the cytoplasmic destruction complex and the nuclear CTNNB1/T-cell-specific transcription factor/lymphoid enhancer binding factor transcriptional complex) are all involved in HCC. Although the non-canonical Wnt pathway is rarely reported, two main non-canonical pathways, Wnt/planar cell polarity pathway and Wnt/Ca(2+) pathway, participate in the regulation of hepatocarcinogenesis. Interestingly, the canonical Wnt pathway is antagonized by non-canonical Wnt signaling in HCC. Moreover, other signaling cascades have also been demonstrated to regulate the Wnt pathway through crosstalk in HCC pathogenesis. This review provides a perspective on the emerging evidence that the aberrant regulation of Wnt signaling is a critical mechanism for the development of HCC. Furthermore, crosstalk between different signaling pathways might be conducive to the development of novel molecular targets of HCC.
???displayArticle.pubmedLink??? 27672271
???displayArticle.pmcLink??? PMC5011664
???displayArticle.link??? World J Gastroenterol
Species referenced: Xenopus
Genes referenced: apc axin1 btrc cdh1 cdk14 csnk1a1 csnk1e ctnnb1 dvl1 dvl2 fyn fzd1 gnat1 gsk3b hgf hif1a igf1 itk lrp5 lrp6 mtor prkci rac1 rap1a rap1b rhoa ror2 smad10 smad3 smad4 stat3 stat3.2 tcf4 tgfb1 tle1 wnt11 wnt5a
GO keywords: Wnt signaling pathway [+]
???displayArticle.disOnts??? hepatocellular carcinoma
???displayArticle.omims??? HEPATOCELLULAR CARCINOMA
???attribute.lit??? ???displayArticles.show???
|
|
|
|
Figure 1. Canonical wingless/int-1signaling pathway. Three complexes are involved in the dynamic activating event: (1) the cell-surface receptor complex; (2) the destruction complex in the cytoplasm; and (3) the CTNNB1/TCF/LEF transcriptional complex in the nucleus. In a normal steady state, there are two pools for CTNNB1 in cells. One is known to interact with CDH1 at the cell-cell junction. The second is present in the destruction complex in cytoplasm, which is assembled by the scaffold proteins AXIN, APC, GSK3β, and CSNK1A1. CSNK1A1 and GSK3β phosphorylate CTNNB1 in the AXIN complex. Phosphorylated CTNNB1 is subsequently recognized and ubiquitinated by BTRC. In the absence of nuclear CTNNB1 translocated from the cytoplasm, TCF/LEF proteins bind to DNA and act as transcriptional repressors by binding to TLE1 proteins. These in turn interact with histone deacetylases whose activities lead to the transcriptional silence of chromatin. The binding of Wnts to FZDs, which form the cell-surface receptor complex, promotes the binding of scaffold proteins such as DVL to the FZD intracellular domains. This subsequently induces the aggregation and phosphorylation of LRP6 and the translocation of AXIN. Phosphorylated LRP6 also recruits AXIN to LRP6 on the plasma membrane. This allows AXIN to be inactivated, which then inhibits CTNNB1 phosphorylation. This in turn allows CTNNB1 to escape degradation, accumulate in the cytoplasm, and translocate to the nucleus. In the nucleus, CTNNB1 interacts primarily with members of the TCF/LEF family of transcription factors and triggers the activation of multiple intracellular signaling cascades. This results in the regulation of various cellular functions. CTNNB1: Catenin beta 1; TCF/LEF: T-cell-specific transcription factor/lymphoid enhancer binding factor; CDH1: Cell adhesion molecule cadherin 1; APC: Adenomatous polyposis coli; GSK3β: GSK3B, glycogen synthase kinase 3 beta; CSNK1A1: Casein kinase 1 alpha 1; FZD: Frizzled class receptor; BTRC: Beta-transducin repeat containing E3 ubiquitin protein ligase. |
|
Figure 2. Non-canonical wingless/int-1 signaling pathway. Non-canonical Wnt pathways are mediated by several possible mechanisms which are independent of the CTNNB1-TCF/LEF transcriptional function, including: (1) Wnt/PCP pathway; (2) Wnt/Ca2+ pathway; (3) Wnt/RTK pathway; (4) Wnt/CSNK1E/Rap1 pathway; (5) Wnt/cAMP/PKA pathway; (6) Wnt/DVL/aPKC pathway; (7) Wnt/GSK3β/MT pathway; (8) Wnt/MTOR pathway; and (9) Wnt/FYN/STAT3 pathway. Lines ending with arrows or bars indicate activating or inhibitory effects respectively. Wnt: Wingless/int-1; CTNNB1: Catenin beta 1; TCF/LEF: T-cell-specific transcription factor/lymphoid enhancer binding factor; PCP: Planar cell polarity; RTK: Receptor tyrosine kinases; CSNK1E: Casein kinase I epsilon; cAMP: Cyclic adenosine monophosphate; PKA: Protein kinase A; DVL: Disheveled; aPKC: Atypical protein kinase C; GSK3β: GSK3B, glycogen synthase kinase 3 beta; MTOR: Mechanistic target of rapamycin; FYN: FYN proto-oncogene, Src family tyrosine kinase; STAT3: Signal transducer and activator of transcription 3. |
|
Figure 3. Regulation of wingless/int-1 signaling by crosstalk in hepatocellular carcinoma. The crosstalk between other signaling cascades and the Wnt signaling pathways involved in hepatocarcinogenesis are shown (see text). Lines ending with arrows or bars indicate activating or inhibitory effects respectively. The distinct line colors indicate the different pathways that crosstalk with Wnt signaling, including: Wnt signaling pathway (black), TGF-β pathway (green), HGF/c-Met pathway (blue), HIF-1α/EMT pathway (yellow), and IGF-1 pathway (purple). Wnt: Wingless/int-1; TGF-β: Transforming growth factor beta; HGF: Hepatocyte growth factor; HIF-1α: Hypoxia- inducible factor-1 alpha; EMT: Epithelial-mesenchymal transition; IGF-1: Insulin/insulin-like growth factor-1. |
References [+] :
Aberle,
beta-catenin is a target for the ubiquitin-proteasome pathway.
1997, Pubmed
Aberle, beta-catenin is a target for the ubiquitin-proteasome pathway. 1997, Pubmed
Amit, Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. 2002, Pubmed
Anastas, WNT signalling pathways as therapeutic targets in cancer. 2013, Pubmed
Angers, Proximal events in Wnt signal transduction. 2009, Pubmed
Axelrod, Progress and challenges in understanding planar cell polarity signaling. 2009, Pubmed
Bai, Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling. 2015, Pubmed
Ban, GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma. 2003, Pubmed
Behrens, Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. 1998, Pubmed , Xenbase
Bengochea, Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. 2008, Pubmed
Cadigan, TCFs and Wnt/β-catenin signaling: more than one way to throw the switch. 2012, Pubmed
Cadoret, Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. 2001, Pubmed
Calvisi, Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. 2005, Pubmed
Calvisi, Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. 2001, Pubmed
Cetin, Downregulation of VANGL1 inhibits cellular invasion rather than cell motility in hepatocellular carcinoma cells without stimulation. 2015, Pubmed
Chan, Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. 2006, Pubmed
Chen, The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. 2016, Pubmed
Chen, A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. 1999, Pubmed
Choi, HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. 2010, Pubmed
Ciani, c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate Dishevelled-mediated microtubule stability. 2007, Pubmed
Colnot, Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. 2004, Pubmed
Cui, Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. 2003, Pubmed
Desbois-Mouthon, Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. 2001, Pubmed
Desbois-Mouthon, Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells. 2002, Pubmed
Devereux, CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. 2001, Pubmed
Dihlmann, The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. 2001, Pubmed
Ding, Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. 2009, Pubmed
Ding, Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation. 2014, Pubmed
Dong, The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells. 2016, Pubmed
Ezzoukhry, EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib. 2012, Pubmed
Fang, Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a. 2013, Pubmed
Feng, Conditional disruption of Axin1 leads to development of liver tumors in mice. 2012, Pubmed
Ferlay, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. 2015, Pubmed
Fischer, PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. 2007, Pubmed
Freyberg, Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. 2010, Pubmed
Fujii, Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. 2004, Pubmed
Fukutomi, Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. 2005, Pubmed
Gómez-Orte, Multiple functions of the noncanonical Wnt pathway. 2013, Pubmed
Gordon, Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. 2006, Pubmed
Green, The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction. 2014, Pubmed
Gujral, A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. 2014, Pubmed , Xenbase
Harada, Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. 2004, Pubmed
Haramis, Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. 2006, Pubmed
Hoshida, Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. 2009, Pubmed
Hotulainen, Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. 2006, Pubmed
Hsieh, Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. 2011, Pubmed
Huang, Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation. 2011, Pubmed
Huang, Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. 1999, Pubmed
Inoki, TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. 2006, Pubmed
Ishizaki, Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. 2004, Pubmed
James, Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. 2008, Pubmed
Jennings, The Groucho/TLE/Grg family of transcriptional co-repressors. 2008, Pubmed
Jian, Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. 2006, Pubmed
Jiang, Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. 2009, Pubmed
Jiang, Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. 2007, Pubmed
Jones, Secreted Frizzled-related proteins: searching for relationships and patterns. 2002, Pubmed
Kalluri, The basics of epithelial-mesenchymal transition. 2009, Pubmed
Kawai-Kitahata, Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features. 2016, Pubmed
Kawate, Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression. 1999, Pubmed
Kikuchi, Multiplicity of the interactions of Wnt proteins and their receptors. 2007, Pubmed
Kikuchi, Selective activation mechanisms of Wnt signaling pathways. 2009, Pubmed
Kim, Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma. 2016, Pubmed
Kim, Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma. 2008, Pubmed
Kim, CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. 2016, Pubmed
Kim, Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. 2008, Pubmed
Kimelman, beta-catenin destruction complex: insights and questions from a structural perspective. 2006, Pubmed
Koga, Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling. 2012, Pubmed
Kohn, Wnt and calcium signaling: beta-catenin-independent pathways. 2005, Pubmed
Kremenevskaja, Wnt-5a has tumor suppressor activity in thyroid carcinoma. 2005, Pubmed
Lachenmayer, Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. 2012, Pubmed
Lai, β-catenin plays a key role in metastasis of human hepatocellular carcinoma. 2011, Pubmed
Laurent-Puig, Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. 2001, Pubmed
Lee, Wnt/Frizzled signaling in hepatocellular carcinoma. 2006, Pubmed
Lian, Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. 2006, Pubmed
Liu, Aberrant regulation of alternative pre-mRNA splicing in hepatocellular carcinoma. 2014, Pubmed
Liu, Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. 2011, Pubmed
Lu, β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma. 2014, Pubmed
Lu, Hypoxia and hypoxia-inducible factors: master regulators of metastasis. 2010, Pubmed
Ma, Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. 2015, Pubmed
Maye, Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. 2004, Pubmed
Merle, Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. 2004, Pubmed
Monga, Role of Wnt/β-catenin signaling in liver metabolism and cancer. 2011, Pubmed
Monga, Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. 2002, Pubmed
Nakamura, Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver. 2007, Pubmed
Nejak-Bowen, Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. 2010, Pubmed
Niehrs, The complex world of WNT receptor signalling. 2012, Pubmed
Nishita, Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. 2006, Pubmed
Nomachi, Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. 2008, Pubmed
Pang, Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells. 2007, Pubmed
Papkoff, The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway. 1987, Pubmed
Park, Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. 2009, Pubmed
Patil, Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis. 2009, Pubmed
Peng, NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. 2016, Pubmed
Quan, Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. 2014, Pubmed
Rebouissou, Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression. 2016, Pubmed
Revill, Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. 2013, Pubmed
Rogacki, Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus. 2015, Pubmed
Satoh, AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. 2000, Pubmed
Schambony, Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. 2007, Pubmed , Xenbase
Schmitt-Graeff, Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. 2005, Pubmed
Schwarz-Romond, Dynamic recruitment of axin by Dishevelled protein assemblies. 2007, Pubmed
Schwarz-Romond, The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. 2007, Pubmed
Semenov, SnapShot: Noncanonical Wnt Signaling Pathways. 2007, Pubmed
Shang, FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis. 2015, Pubmed
Shih, Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. 2006, Pubmed
Shih, SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. 2007, Pubmed
Shu, Functional characterization of human PFTK1 as a cyclin-dependent kinase. 2007, Pubmed
Simons, Planar cell polarity signaling: from fly development to human disease. 2008, Pubmed
Stauffer, Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors. 2011, Pubmed
Steinbach, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. 2000, Pubmed
Steinway, Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. 2014, Pubmed
Street, Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. 2005, Pubmed
Sun, PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma. 2014, Pubmed
Takigawa, Wnt signaling in liver cancer. 2008, Pubmed
Tan, Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. 2005, Pubmed
Taniguchi, Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. 2002, Pubmed
Thompson, WNT/beta-catenin signaling in liver health and disease. 2007, Pubmed
Tornesello, Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. 2016, Pubmed
Toyama, Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. 2010, Pubmed
Tsai, A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein. 2007, Pubmed , Xenbase
Tung, Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. 2012, Pubmed
Tuynman, Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. 2008, Pubmed
Tward, Distinct pathways of genomic progression to benign and malignant tumors of the liver. 2007, Pubmed
Vermeulen, Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. 2010, Pubmed
Wang, In vitro antiproliferative and antioxidant effects of urolithin A, the colonic metabolite of ellagic acid, on hepatocellular carcinomas HepG2 cells. 2015, Pubmed
Wang, Structure-function analysis of Frizzleds. 2006, Pubmed
Wege, Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes. 2011, Pubmed
Wei, Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. 2011, Pubmed
Weivoda, Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. 2016, Pubmed
White, Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. 2012, Pubmed
Whittaker, The role of signaling pathways in the development and treatment of hepatocellular carcinoma. 2010, Pubmed
Xie, Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. 2014, Pubmed
Yang, Identification and cellular localization of human PFTAIRE1. 2001, Pubmed
Yau, HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. 2005, Pubmed , Xenbase
Yong, Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. 2016, Pubmed
Yoon, Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway. 2011, Pubmed
Yuzugullu, Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. 2009, Pubmed
Zhang, Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. 2013, Pubmed
Zhang, Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. 2012, Pubmed
Zhang, Dishevelled promotes axon differentiation by regulating atypical protein kinase C. 2007, Pubmed
Zhang, Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. 2016, Pubmed
Zhang, Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma. 2013, Pubmed
Zhao, Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. 2004, Pubmed
Zhi, βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. 2015, Pubmed
Zhu, miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity. 2015, Pubmed